RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

Sponsored by Abbott

Discussants: M. Adamo, E. Donal, G. Nickenig, R. S. von Bardeleben, G. Filippatos

Procedural Analyst: N. Ajmone Marsan

Summary

Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how their results could influence the treatment of mitral and tricuspid disease in your clinical practice.

Learning Objectives

To learn more about the outcomes of recent pivotal randomised clinical trials
To assess the impact of the RESHAPE, MATTERHORN and Tri.FR trial outcomes on your daily clinical practice
To anticipate future trends in the treatment of mitral and tricuspid valve disease